Khaled El Emam, SVP & GM, Replica Analytics
Presentation describing a method for the synthesis of complex clinical trial data and explaining how to tune its hyperparameters, with results presented on multiple oncology clinical trial datasets.
Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.